Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-08 · accession 0001104659-24-060000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-10 | 2024-05-08 | OBIO | Sherman Darren | See Remarks, Dir | A - Grant | $0.00 | +176.7K | 800.1K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2024-05-08 | A | A | 176,667 | $0.00 | 800,112 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 26,500 RSUs will vest on May 25, 2025, and (ii) the remaining 150,167 RSUs will vest in equal installments on August 25, 2025, November 25, 2025, December 22, 2025, May 25, 2026, August 25, 2026, December 22, 2026, March 25, 2027, May 25, 2027, August 25, 2027, November 25, 2027, March 25, 2028 and May 25, 2028, subject to the Reporting Person's continuous service through such dates. |